Denmark Per Jørgensen, deputy director of Copenhagen University Hospital (Rigshospitalet), discusses pandemic management, clinical trial collaborations with private industry, translational research, and the demands that the hospitals of the future will need to adapt to. Big and specialized hospitals in Denmark such as ours are in a unique position to…
Colombia The Top 10 pharma companies in the Colombian pharma market ranked by operating income for the year 2020. Local players Droguerías y Farmacias Cruz Verde, Audifarma, Copidrogas, Tecnoquimicas, and Copservir make up the top five spots. German giant Bayer in sixth position is the highest placed multinational. Made with Visme…
USA PhRMA’s Lori Reilly warns that, as US policymakers seek to reduce drug prices, they must avoid policies that reduce access and choice. America is the centre of cutting-edge biopharmaceutical innovation. Not only are many of the latest treatments and cures developed in labs by researchers across the United States,…
Denmark Petter Hartman of the Medicon Valley Alliance, a non-profit membership organisation spanning the Danish-Swedish life science cluster Medicon Valley, introduces the progress of the Alliance from a networking body to today facilitating concrete collaborations between its 300+ members. Hartmann also touches on the MVA’s key focus areas, talent hiring and…
Europe The Lymphoma Coalition’s Natacha Bolaños outlines the fundamentals of the lymphoma patient experience today, the growing number of innovative new treatment options available, and the issues surrounding their integration as earlier lines of treatment. CAR-T is not necessarily the best treatment option for everyone. There could be other second-best…
Saudi Arabia Saudi Arabia has one of the highest rates of diabetes in the world – over 17 percent of the population are diabetic – making the supply of insulin products a matter of significant national interest. To this end, the recent Memorandum of Understanding (MoU) signed between historic US diabetes leader…
Denmark Since joining Danish neuroscience specialist Lundbeck as its global CEO in 2018, South African Deborah Dunsire has focused on “revitalising and refreshing” the firm’s pipeline, which had seen several failures in the preceding years. In an exclusive recent conversation with PharmaBoardroom, Dunsire explains the strategy she has put in place…
Global Paula Barbosa, head of influenza policy and advocacy at the IFPMA and board member of the #TogetherAgainstFlu campaign, looks ahead to what could be a devastating 2021/22 flu season, with natural immunity among vulnerable populations down following the pandemic induced lockdowns and preventive measures of last year. Barbosa lays out…
Norway Norway has been a global frontrunner in collecting health data and building unique registries for decades but has struggled to utilise and benefit from them. Karita Bekkemellem, CEO of the Association of the Pharmaceutical Industry in Norway (LMI), examines how a new health data sharing platform can change that— to…
Saudi Arabia Kamel Ghammachi and Karim Smaira are the co-founders of Genpharm, an entrepreneurial success story that now provides market access and marketing solutions for rare disease products across the MENA region. They discuss the impact of COVID-19 on their business; the evolving dynamics of the Saudi pharma market; and the crucial…
Switzerland Swiss-based Lonza has consolidated as a titan in the CDMO industry with annual revenues of around CHF 5.9bn for 2020. Its president for the Biologics and Cell & Gene divisions, Jean-Christophe Hyvert, comments on the restructuring of the company, why the divesture of the specialty ingredients division makes sense in…
Turkey Amgen, the American biotech giant, established a direct presence in Turkey in 2010 by acquiring a local generics manufacturer for US 700 million. Its general manager in the country, Güldem Berkman, explains why their Turkish operations and business model differs from all other affiliates with the exception of Brazil, provides…
See our Cookie Privacy Policy Here
